CLINICAL_TRIALS ClinicalTrials.gov record update

Pilot Study of Intravitreal Bevacizumab vs. Combination Therapy for Choroidal Neovascularization Secondary to Causes Other Than Age-related Macular Degeneration

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01256580
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:35:34.428333+00:00
Published At: 2014-01-14T00:00:00+00:00
Record Updated At: 2014-01-14
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Choroidal Neovascularization", "Myopia", "Punctate Inner Choroidopathy (PIC)", "Multifocal Choroiditis", "Ocular Histoplasmosis Syndrome", "Central Serous Chorioretinopathy (CSC)", "Angioid Streaks", "Trauma, or Hereditary Eye Diseases"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2014-01-14"
protocolSection.identificationModule.nctId: "NCT01256580"
protocolSection.identificationModule.officialTitle: "Pilot Study of Intravitreal Bevacizumab vs. Combination Therapy for Choroidal Neovascularization Secondary to Causes Other Than Age-related Macular Degeneration"
protocolSection.statusModule.overallStatus: "WITHDRAWN"
protocolSection.designModule.phases: ["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.